Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy

Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy

There are few reports of conversion surgery (CS) after nivolumab monotherapy because it is considered as a third-line standard chemotherapy for unresectable or recurrent gastric cancer. Here, we report a rare case of stage IV gastric cancer effectively treated with CS after nivolumab monotherapy as...

Full description

Bibliographic Details
Main Authors: Hayato Watanabe, Hirohito Fujikawa, Keisuke Komori, Kazuki Kano, Kosuke Takahashi, Takanobu Yamada, Yasuhiro Inokuchi, Nozomu Machida, Tomoyuki Yokose, Yasushi Rino, Munetaka Masuda, Takashi Ogata, Takashi Oshima
Format: Article
Language:English
Published: Karger Publishers 2021-06-01
Series:Case Reports in Gastroenterology
Subjects:
nivolumab
conversion surgery
gastric cancer
Online Access:https://www.karger.com/Article/FullText/514396

Internet

https://www.karger.com/Article/FullText/514396

Similar Items